Parabiotic R&D

Seeking to treat the stymptoms or Ulcerative Colitus, Parabiotic R&D has patented a combined treatment modality to treat, re-establish, and maintain the GI tract.

  • Presenter: Ira Trachtman, Founder and President
  • Commercial Catalyst: Caroline Hoedemaker and Paul Jeffrey
  • Defined Milestone: Re – define position in competitive space
  • Targeted Completion: 1 month